FDA approves Niktimvo for chronic graft-versus-host disease
Drug Discovery World
AUGUST 20, 2024
It is approved for use after the failure of at least two prior lines of systemic therapy in adult and paediatric patients weighing at least 40kg. Diana Spencer, Senior Digital Content Editor, DDW The post FDA approves Niktimvo for chronic graft-versus-host disease appeared first on Drug Discovery World (DDW).
Let's personalize your content